Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3989.87x is 197% below its 2-year average of -1343.38x, around the middle of its 2-year range (-6583.27x–-4.69x).
As of the fiscal period ended Thursday, June 30, 2022. 49.01% below its 12-month average of -2677.53x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-06-30): -3989.87x.
INTEREST COVERAGE RATIO
-3989.87x
INTEREST COVERAGE RATIO AVG TTM
-2677.53x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-49.01%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-62486.18%
vs the sector median at left
Neuphoria Therapeutics Inc.
Market Cap
$18.65M
Interest Coverage Ratio
-3989.87x
TTM Avg
-2677.53x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.15M
Interest Coverage Ratio
-4.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.42M
Interest Coverage Ratio
-1110.88x
TTM Avg
1344.27x
3Y Avg
1344.27x
5Y Avg
1344.27x
Market Cap
$19.77M
Interest Coverage Ratio
-24.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.39M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$17.31M
Interest Coverage Ratio
N/A
TTM Avg
15.47x
3Y Avg
15.47x
5Y Avg
15.47x
Market Cap
$16.84M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$16.82M
Interest Coverage Ratio
-49.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | $18.65M | -3989.87x | -2677.53x | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.15M | -4.91x | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.42M | -1110.88x | 1344.27x | 1344.27x | 1344.27x |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.77M | -24.74x | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -6.31x | 0.97x | 0.97x | 0.97x |
| Lipocine Inc. (LPCN)vs › | $17.31M | N/A | 15.47x | 15.47x | 15.47x |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | N/A | 1.00x | 1.00x | 1.00x |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -49.05x | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -1288.77x | 51.73x | 51.73x | 51.73x |
Interest Coverage
-3989.9x
Debt/Equity
0.00
Current Ratio
27.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -3989.87x |
| 2022-03-31 | -6583.27x |
| 2021-12-31 | -1401.93x |
| 2021-09-30 | -1402.00x |
| 2021-06-30 | -10.58x |
| 2021-03-31 | -10.58x |
| 2020-12-31 | -13.10x |
| 2020-09-30 | -13.10x |
| 2020-06-30 | -4.69x |
| 2020-03-31 | -4.69x |
